{"name":"Latterell Venture Partners","permalink":"latterell-venture-partners","crunchbase_url":"http://www.crunchbase.com/financial-organization/latterell-venture-partners","homepage_url":"http://www.lvpcapital.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"4153999880","description":"Early stage healthcare","email_address":"","number_of_employees":7,"founded_year":2001,"founded_month":null,"founded_day":null,"tag_list":"","alias_list":"","created_at":"Fri Apr 10 14:30:01 UTC 2009","updated_at":"Tue Aug 04 02:19:07 UTC 2009","overview":"<p>Latterell Venture Partners invests in early stage healthcare companies with innovative technologies, large market opportunities, and passionate entrepreneurs. We offer a unique blend of venture capital, entrepreneurial, technical, clinical and collaborative skills which enable us to help entrepreneurs create highly successful new startups. LVP is committed to building a portfolio of outstanding biotechnology and medical device companies which produce excellent returns for our limited partners while providing major new disease treatments to help patients worldwide.</p>","image":{"available_sizes":[[[150,21],"assets/images/resized/0005/5132/55132v2-max-150x150.png"],[[250,36],"assets/images/resized/0005/5132/55132v2-max-250x250.png"],[[287,42],"assets/images/resized/0005/5132/55132v2-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"One Embarcadero Center","address2":"Suite 4050","zip_code":"94111","city":"San Francisco","state_code":"CA","country_code":"USA","latitude":37.794891,"longitude":-122.397901}],"relationships":[{"is_past":false,"title":"","person":{"first_name":"Paul","last_name":"Edwards","permalink":"paul-edwards","image":null}},{"is_past":false,"title":"","person":{"first_name":"Peter","last_name":"Fitzgerald","permalink":"peter-fitzgerald","image":null}},{"is_past":false,"title":"","person":{"first_name":"Ken","last_name":"Widder","permalink":"ken-widder","image":null}},{"is_past":false,"title":"","person":{"first_name":"Pat","last_name":"Latterell","permalink":"pat-latterell","image":null}},{"is_past":false,"title":"","person":{"first_name":"Dalton","last_name":"Einhorn","permalink":"dalton-einhorn","image":null}},{"is_past":false,"title":"","person":{"first_name":"Steve","last_name":"Salmon","permalink":"steve-salmon","image":null}},{"is_past":false,"title":"","person":{"first_name":"Jim","last_name":"Woody","permalink":"jim-woody","image":null}},{"is_past":false,"title":"Venture Partner","person":{"first_name":"James","last_name":"Woody","permalink":"james-woody","image":null}}],"investments":[{"funding_round":{"round_code":"c","source_url":"http://www.pehub.com/?p=36872","source_description":"Cell Biosciences Raises $10 Million","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":4,"funded_day":10,"company":{"name":"ProteinSimple","permalink":"cell-biosciences","image":{"available_sizes":[[[150,39],"assets/images/resized/0004/0799/40799v3-max-150x150.jpg"],[[171,45],"assets/images/resized/0004/0799/40799v3-max-250x250.jpg"],[[171,45],"assets/images/resized/0004/0799/40799v3-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://venturebeat.com/2009/03/30/pathway-medical-lands-generous-40m-to-treat-arterial-disease/","source_description":"Pathway Medical lands generous $40M to treat arterial disease","raised_amount":42500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":3,"funded_day":1,"company":{"name":"Pathway Medical Technologies","permalink":"pathway-medical-technologies","image":{"available_sizes":[[[150,37],"assets/images/resized/0004/1072/41072v1-max-150x150.png"],[[222,56],"assets/images/resized/0004/1072/41072v1-max-250x250.png"],[[222,56],"assets/images/resized/0004/1072/41072v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/transcend-medical-pockets-35m-second-venture-round/2009-06-22?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"Transcend Medical pockets $35M in VC","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":1,"company":{"name":"Transcend Medical","permalink":"transcend-medical","image":{"available_sizes":[[[150,83],"assets/images/resized/0004/7772/47772v4-max-150x150.jpg"],[[199,111],"assets/images/resized/0004/7772/47772v4-max-250x250.jpg"],[[199,111],"assets/images/resized/0004/7772/47772v4-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://venturebeat.com/2007/05/29/talima-therapeutics-raises-19m-for-site-specific-drugs/","source_description":"Talima Therapeutics raises $19M for site-specific drugs","raised_amount":19000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":5,"funded_day":29,"company":{"name":"Talima Therapeutics","permalink":"talima-therapeutics","image":{"available_sizes":[[[136,65],"assets/images/resized/0005/9562/59562v1-max-150x150.jpg"],[[136,65],"assets/images/resized/0005/9562/59562v1-max-250x250.jpg"],[[136,65],"assets/images/resized/0005/9562/59562v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://venturebeat.com/2007/05/07/lung-device-maker-pulmonx-draws-in-20m/","source_description":"Lung-device maker Pulmonx draws in $20M","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":5,"funded_day":7,"company":{"name":"Pulmonx","permalink":"pulmonx","image":{"available_sizes":[[[150,74],"assets/images/resized/0005/9579/59579v1-max-150x150.png"],[[165,82],"assets/images/resized/0005/9579/59579v1-max-250x250.png"],[[165,82],"assets/images/resized/0005/9579/59579v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.socaltech.com/femta_pharmaceuticals_raises__m/s-0022911.html","source_description":"Femta Pharmaceuticals Raises $1M","raised_amount":1000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":7,"funded_day":17,"company":{"name":"Femta Pharmaceuticals","permalink":"femta-pharmaceuticals","image":{"available_sizes":[[[150,49],"assets/images/resized/0006/1175/61175v1-max-150x150.jpg"],[[250,82],"assets/images/resized/0006/1175/61175v1-max-250x250.jpg"],[[312,103],"assets/images/resized/0006/1175/61175v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.bio-medicine.org/biology-technology-1/Cell-Biosciences-Announces-New-Leadership-6227-2/","source_description":"Bio-Medicine","raised_amount":27000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":1,"funded_day":1,"company":{"name":"ProteinSimple","permalink":"cell-biosciences","image":{"available_sizes":[[[150,39],"assets/images/resized/0004/0799/40799v3-max-150x150.jpg"],[[171,45],"assets/images/resized/0004/0799/40799v3-max-250x250.jpg"],[[171,45],"assets/images/resized/0004/0799/40799v3-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/pulmonx-inc-series-c-32m/","source_description":"Pulmonx, Inc.: Series C $32M","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":8,"company":{"name":"Pulmonx","permalink":"pulmonx","image":{"available_sizes":[[[150,74],"assets/images/resized/0005/9579/59579v1-max-150x150.png"],[[165,82],"assets/images/resized/0005/9579/59579v1-max-250x250.png"],[[165,82],"assets/images/resized/0005/9579/59579v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/ovalis-inc-series-b-66m/","source_description":"Ovalis, Inc.: Series B $6.6M","raised_amount":6600000,"raised_currency_code":"USD","funded_year":2007,"funded_month":1,"funded_day":30,"company":{"name":"Ovalis","permalink":"ovalis","image":null}}},{"funding_round":{"round_code":"b","source_url":"http://www.biospace.com/news_story.aspx?NewsEntityId=115682","source_description":"OncoMed Pharmaceuticals, Inc. Completes $154 Million Series B Financing ","raised_amount":154000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":11,"funded_day":4,"company":{"name":"OncoMed Pharmaceuticals","permalink":"oncomed-pharmaceuticals","image":{"available_sizes":[[[150,46],"assets/images/resized/0008/4217/84217v1-max-150x150.jpg"],[[193,60],"assets/images/resized/0008/4217/84217v1-max-250x250.jpg"],[[193,60],"assets/images/resized/0008/4217/84217v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/tetralogic-nabs-32m-round-lead-cancer-therapy/2010-08-10?utm_medium=rss&utm_source=rss","source_description":"TetraLogic nabs $32M round for lead cancer therapy  Read more: TetraLogic nabs $32M round for lead cancer therapy","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":10,"company":{"name":"TetraLogic Pharmaceuticals","permalink":"tetralogic-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0009/8561/98561v1-max-150x150.png"],[[250,72],"assets/images/resized/0009/8561/98561v1-max-250x250.png"],[[270,78],"assets/images/resized/0009/8561/98561v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.calistogapharma.com/pdf/FINAL%20CALPharma%20Series%20C%20release%206.30.10.pdf","source_description":"Calistoga Pharmaceuticals Raises $40 Million in Series C Financing","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":30,"company":{"name":"Calistoga Pharmaceuticals","permalink":"calistoga-pharmaceuticals","image":{"available_sizes":[[[150,85],"assets/images/resized/0005/2159/52159v2-max-150x150.jpg"],[[217,124],"assets/images/resized/0005/2159/52159v2-max-250x250.jpg"],[[217,124],"assets/images/resized/0005/2159/52159v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/femta-pharmaceuticals-inc-series-a-22m/","source_description":"Femta Pharmaceuticals, Inc.: Series A $22M","raised_amount":22000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":12,"company":{"name":"Femta Pharmaceuticals","permalink":"femta-pharmaceuticals","image":{"available_sizes":[[[150,49],"assets/images/resized/0006/1175/61175v1-max-150x150.jpg"],[[250,82],"assets/images/resized/0006/1175/61175v1-max-250x250.jpg"],[[312,103],"assets/images/resized/0006/1175/61175v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"f","source_url":"http://www.xconomy.com/san-francisco/2010/10/14/cell-biosciences-nabs-20m-buys-convergent/","source_description":"Cell Biosciences Nabs $20M","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":14,"company":{"name":"ProteinSimple","permalink":"cell-biosciences","image":{"available_sizes":[[[150,39],"assets/images/resized/0004/0799/40799v3-max-150x150.jpg"],[[171,45],"assets/images/resized/0004/0799/40799v3-max-250x250.jpg"],[[171,45],"assets/images/resized/0004/0799/40799v3-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.fiercebiotech.com/story/naurex-raises-18m-ph2-depression-program/2011-05-11?utm_medium=rss&utm_source=rss","source_description":"Naurex raises $18M for Ph2 depression program","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":5,"funded_day":11,"company":{"name":"Naurex","permalink":"naurex","image":{"available_sizes":[[[150,49],"assets/images/resized/0013/4243/134243v1-max-150x150.jpg"],[[240,79],"assets/images/resized/0013/4243/134243v1-max-250x250.jpg"],[[240,79],"assets/images/resized/0013/4243/134243v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://money.msn.com/business-news/article.aspx?feed=PR&Date=20111108&ID=14499036","source_description":"Inova Labs Closes on $17.5M Series B Financing","raised_amount":17500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":11,"funded_day":8,"company":{"name":"Inova Labs","permalink":"inova-labs","image":{"available_sizes":[[[150,61],"assets/images/resized/0016/1502/161502v1-max-150x150.png"],[[196,81],"assets/images/resized/0016/1502/161502v1-max-250x250.png"],[[196,81],"assets/images/resized/0016/1502/161502v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/transcend-medical-inc-series-b-16m/","source_description":"Transcend Medical, Inc.: Series B $16M","raised_amount":16000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":17,"company":{"name":"Transcend Medical","permalink":"transcend-medical","image":{"available_sizes":[[[150,83],"assets/images/resized/0004/7772/47772v4-max-150x150.jpg"],[[199,111],"assets/images/resized/0004/7772/47772v4-max-250x250.jpg"],[[199,111],"assets/images/resized/0004/7772/47772v4-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.neuraltus.com/pages/news_rel03_26_09.html","source_description":"Neuraltus Pharmaceuticals Raises $17 Million Series A Funding ","raised_amount":17000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":3,"funded_day":26,"company":{"name":"Neuraltus Pharmaceuticals","permalink":"neuraltus-pharmaceuticals","image":{"available_sizes":[[[100,98],"assets/images/resized/0017/2416/172416v1-max-150x150.png"],[[100,98],"assets/images/resized/0017/2416/172416v1-max-250x250.png"],[[100,98],"assets/images/resized/0017/2416/172416v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/neuraltus-pharmaceuticals-inc-series-b-96m/","source_description":"Neuraltus Pharmaceuticals, Inc.: Series B $9.6M","raised_amount":9600000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":31,"company":{"name":"Neuraltus Pharmaceuticals","permalink":"neuraltus-pharmaceuticals","image":{"available_sizes":[[[100,98],"assets/images/resized/0017/2416/172416v1-max-150x150.png"],[[100,98],"assets/images/resized/0017/2416/172416v1-max-250x250.png"],[[100,98],"assets/images/resized/0017/2416/172416v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.hemaquest.com/inc/HemaQuestAnnounces13MillionFinancing.asp","source_description":"HemaQuest Pharmaceuticals Raises $13 Million in Series B Extension Financing","raised_amount":13000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":3,"funded_day":12,"company":{"name":"HemaQuest Pharmaceuticals","permalink":"hemaquest","image":{"available_sizes":[[[150,34],"assets/images/resized/0008/4530/84530v1-max-150x150.png"],[[250,57],"assets/images/resized/0008/4530/84530v1-max-250x250.png"],[[254,58],"assets/images/resized/0008/4530/84530v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}